225 related articles for article (PubMed ID: 34600826)
1. ChREBP deficiency alleviates apoptosis by inhibiting TXNIP/oxidative stress in diabetic nephropathy.
Chen N; Song S; Yang Z; Wu M; Mu L; Zhou T; Shi Y
J Diabetes Complications; 2021 Dec; 35(12):108050. PubMed ID: 34600826
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate response element-binding protein regulates lipid metabolism via mTOR complex1 in diabetic nephropathy.
Chen N; Mu L; Yang Z; Du C; Wu M; Song S; Yuan C; Shi Y
J Cell Physiol; 2021 Jan; 236(1):625-640. PubMed ID: 32583421
[TBL] [Abstract][Full Text] [Related]
3. Expression and pathophysiological significance of carbohydrate response element binding protein (ChREBP) in the renal tubules of diabetic kidney.
Suzuki S; Yokoyama A; Noro E; Aoki S; Shimizu K; Shimada H; Sugawara A
Endocr J; 2020 Mar; 67(3):335-345. PubMed ID: 31813922
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice.
Wu M; Han W; Song S; Du Y; Liu C; Chen N; Wu H; Shi Y; Duan H
Mol Cell Endocrinol; 2018 Dec; 478():115-125. PubMed ID: 30098377
[TBL] [Abstract][Full Text] [Related]
6. Redox regulation by nuclear factor erythroid 2-related factor 2: gatekeeping for the basal and diabetes-induced expression of thioredoxin-interacting protein.
He X; Ma Q
Mol Pharmacol; 2012 Nov; 82(5):887-97. PubMed ID: 22869588
[TBL] [Abstract][Full Text] [Related]
7. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
[TBL] [Abstract][Full Text] [Related]
8. High glucose-induced O-GlcNAcylated carbohydrate response element-binding protein (ChREBP) mediates mesangial cell lipogenesis and fibrosis: the possible role in the development of diabetic nephropathy.
Park MJ; Kim DI; Lim SK; Choi JH; Han HJ; Yoon KC; Park SH
J Biol Chem; 2014 May; 289(19):13519-30. PubMed ID: 24616092
[TBL] [Abstract][Full Text] [Related]
9. FMK, an Inhibitor of p90RSK, Inhibits High Glucose-Induced TXNIP Expression via Regulation of ChREBP in Pancreatic β Cells.
Han JH; Kim S; Kim S; Lee H; Park SY; Woo CH
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505737
[TBL] [Abstract][Full Text] [Related]
10. TXNIP deficiency attenuates renal fibrosis by modulating mTORC1/TFEB-mediated autophagy in diabetic kidney disease.
Du Y; Wu M; Song S; Bian Y; Shi Y
Ren Fail; 2024 Dec; 46(1):2338933. PubMed ID: 38616177
[TBL] [Abstract][Full Text] [Related]
11. FOXO1 Overexpression Attenuates Tubulointerstitial Fibrosis and Apoptosis in Diabetic Kidneys by Ameliorating Oxidative Injury via TXNIP-TRX.
Ji L; Wang Q; Huang F; An T; Guo F; Zhao Y; Liu Y; He Y; Song Y; Qin G
Oxid Med Cell Longev; 2019; 2019():3286928. PubMed ID: 30962862
[TBL] [Abstract][Full Text] [Related]
12. mTOR controls ChREBP transcriptional activity and pancreatic β cell survival under diabetic stress.
Chau GC; Im DU; Kang TM; Bae JM; Kim W; Pyo S; Moon EY; Um SH
J Cell Biol; 2017 Jul; 216(7):2091-2105. PubMed ID: 28606928
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells.
Shah A; Xia L; Goldberg H; Lee KW; Quaggin SE; Fantus IG
J Biol Chem; 2013 Mar; 288(10):6835-48. PubMed ID: 23329835
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin-interacting protein mediates dysfunction of tubular autophagy in diabetic kidneys through inhibiting autophagic flux.
Huang C; Lin MZ; Cheng D; Braet F; Pollock CA; Chen XM
Lab Invest; 2014 Mar; 94(3):309-20. PubMed ID: 24492284
[TBL] [Abstract][Full Text] [Related]
15. Celastrol targets the ChREBP-TXNIP axis to ameliorates type 2 diabetes mellitus.
Zhou D; Li X; Xiao X; Wang G; Chen B; Song Y; Liu X; He Q; Zhang H; Wu Q; Zhang L; Wu L; Shen Z; Hassan M; Zhao Y; Zhou W
Phytomedicine; 2023 Feb; 110():154634. PubMed ID: 36603341
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy.
Hou Y; Li S; Wu M; Wei J; Ren Y; Du C; Wu H; Han C; Duan H; Shi Y
Am J Physiol Renal Physiol; 2016 Mar; 310(6):F547-59. PubMed ID: 26719366
[TBL] [Abstract][Full Text] [Related]
17. FOXO1 competes with carbohydrate response element-binding protein (ChREBP) and inhibits thioredoxin-interacting protein (TXNIP) transcription in pancreatic beta cells.
Kibbe C; Chen J; Xu G; Jing G; Shalev A
J Biol Chem; 2013 Aug; 288(32):23194-202. PubMed ID: 23803610
[TBL] [Abstract][Full Text] [Related]
18. Ablation of carbohydrate-responsive element-binding protein improves kidney injury in streptozotocin-induced diabetic mice.
Zhang W; Li X; Zhou SG
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):42-47. PubMed ID: 28121358
[TBL] [Abstract][Full Text] [Related]
19. TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Muller glia under chronic hyperglycemia: implications for diabetic retinopathy.
Devi TS; Lee I; Hüttemann M; Kumar A; Nantwi KD; Singh LP
Exp Diabetes Res; 2012; 2012():438238. PubMed ID: 22474421
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
